Self-efficacy, medical adherence and related factors in patients with diabetes
Yıl: 2021 Cilt: 6 Sayı: 1 Sayfa Aralığı: 13 - 21 Metin Dili: İngilizce DOI: 10.22391/fppc.809768 İndeks Tarihi: 19-04-2022
Self-efficacy, medical adherence and related factors in patients with diabetes
Öz: Introduction: The aim of the current study was to determine the self-efficacy and the medical adherence levels of the patients with type 2 diabetes and related factors in primary care. Methods: This was a descriptive study which was conducted in a family health center in Istanbul between February 2020 and May 2020. Information was collected from the patients over the age of 18 with a diagnosis of type 2 diabetes. A sociodemographic questionnaire form, Self- Efficacy Scale and Morisky Medication Adherence Scale were applied to participants face-to-face. Results: Two hundred and seven patients were included. Mean age of the participants was 59.05±10.74 years. Sixty percent of them were women, 85.0% were over 50 years, 69.9% had an additional disease, about half of them were diagnosed with diabetes for 10 years or more. It was found that individuals with diabetes had a median self-efficacy score of 72(64-79). The self-efficacy scores were higher in patients with normal BMI, those without additional disease and those with high physical activity level (p=0.004, p= 0.038, p=0.002 respectively). The medication adherence level was found medium in 174 (84.1%) of the patients. As the age increased medication adherence also tended to increase, and the adherence of people with normal BMI was higher (p=0.019 and p= 0.026 respectively). Conclusion: The self-efficacy and medical adherence of the diabetic patients participated in the current study were found to be at medium levels. It is understood that steps are needed to improve patients' self-efficacy levels and to increase their compliance with treatment.
Anahtar Kelime: Diyabetli hastalarda öz-etkililik, tedaviye uyum ve ilişkili faktörler
Öz: Giriş: Bu çalışmanın amacı birinci basamakta tip 2 DM tanılı kişilerin öz-etkililik düzeyini ve ilaç tedavisine bağlılığını ve ilişkili faktörleri belirlemektir. Yöntem: Tanımlayıcı tipteki çalışmamız İstanbul ilinde bir aile sağlığı merkezinde Şubat ve Mart 2020 tarihleri arasında yürütülmüştür. On sekiz yaş üstü tip 2 diyabet tanılı hastalardan bilgi toplanmıştır. Sosyodemografik özellikli bir anket, Öz-etkililik Ölçeği ve Morisky Tedavi Uyum Ölçeği katılımcılara yüz yüze uygulanmıştır. Bulgular: 207 hasta çalışmaya dahil edilmiştir. Katılımcıların ortalama yaşı 59.05±10.74 bulunmuştur. Araştırmaya katılanların %60’ı kadın, %85,0’i 50 yaş üstü, %69,9’u ek hastalık sahibi ve yaklaşık yarısı 10 yıl ve üzeri diyabet tanılıdır. Çalışmamız sonuçlarına göre diyabetli bireylerin öz-etkililik ortanca skoru 72(64-79 bulunmuştur. Normal BKI sahip kişilerin, ek hastalığı olmayanların ve fiziksel aktiflik düzeyi yüksek olanların öz-etkililik puanlarının daha yüksek olduğu görülmüştür (sırasıyla p=0.004, p= 0.038, p=0.002) Araştırmamızda 174 (% 84.1) hastanın ilaç uyumu orta düzeyde bulunmuştur. Yaş artıkça ilaç uyumu oranının artma eğilimi tespit edilmiş ve normal vücut kitle indeksine sahip kişilerin tedavi uyumu daha yüksek bulunmuştur (sırasıyla p=0.019 ve p= 0.026 ). Sonuç: Çalışmamıza katılan diyabetli hastaların öz-etkililik skorları ve tedaviye uyumlarının orta seviyelerde olduğu gözlenmiştir. Hastaların öz etkililik düzeylerinin geliştirilmesine ve tedaviye uyumunun arttırılmasına yönelik adımlara ihtiyaç duyulduğu anlaşılmaktadır.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Busolo D, Woodgate R. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review Temd. 2020]; Available from: http://temd.org.tr/admin/uploads/tbl_kilavuz/20200625154506-2020tbl_kilavuz86bf012d90.pdf. (Access date: June 21, 2020)
- 2. Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T, et al., IDF diabetes atlas. 2013. http://dro.deakin.edu.au/view/DU:30060687
- 3. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28:169–80. https://doi.org/10.2337/diacare.24.3.561
- 4. Bandura A. Social foundations of thought and action. Englewood Cliffs, NJ. 1986;1986:23-8.
- 5. Bandura A, Freeman W, Lightsey R. Self-efficacy: The exercise of control. Springer; 1999. https://doi.org/10.1891/0889-8391.13.2.158.
- 6. Norris SL, Engelgau MM, Narayan KMV. Effectiveness of self-management training in type 2 diabetes: A systematic review of randomized controlled trials. Diabetes Care. 2001; 24(3):561-87. https://doi.org/10.2337/diacare.24.3.561
- 7. Krichbaum K, Aarestad V, Buethe M. Exploring the Connection Between Self-Efficacy and Effective Diabetes Self-f Management. The Diabetes Educator. 2003;29(4):653-62. https://doi.org/10.1177/014572170302900411
- 8. Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 2017;
- 99:269-76. https://doi.org/10.1016/j.ypmed.2017.03.008
- 9. Brown MT, Bussell J, Dutta S, Davis K, Strong S and Mathew S. Medication adherence: truth and consequences. The American journal of the medical sciences, 2016; 351(4): 387-99. https://doi.org/10.1016/j.amjms.2016.01.010
- 10. Capoccia K, Odegard PS, Letassy N. Medication adherence with diabetes medication: a systematic review of the literature. Sci Diab Self-Management Care 2016;42(1):34-71. https://doi.org/10.1177/0145721715619038
- 11. Shortridge-Baggett LM. Self-efficacy: measurement and intervention in nursing. Sch Inq Nurs Pract. 2001 Fall;15(3):183-8. https://pubmed.ncbi.nlm.nih.gov/11871578
- 12. Bijl J, Poelgeest‐Eeltink AV and Shortridge‐Baggett L. The psychometric properties of the diabetes management self‐efficacy scale for patients with type 2 diabetes mellitus. J Adv Nurs 1999; 30(2): 352-59. https://doi.org/10.1046/j.1365-2648.1999.01077.x
- 13. Kara M, Van Der Bijl JJ, Shortridge-Baggett L, Asti T, Erguney S. Cross-cultural adaptation of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus: Scale development. Int J Nurs Studies 2006; 43(5):611-21. https://doi.org/10.1016/j.ijnurstu.2005.07.008
- 14. Bahar G, Savas HA, Unal A, Savas E, Kaya H, Bahar A. Reliability and validity of the Morisky Medication Adherence Scale for bipolar mood disorder. Anatol J Psychiatry 2014; 15(2):141-9. http://dx.doi.org/10.5455/apd.39827
- 15. Kav S, Yilmaz AA, Bulut Y and Dogan N. Self-efficacy, depression and self-care activities of people with type 2 diabetes in Turkey. Collegian 2017;24(1):27-35. https://doi.org/10.1016/j.colegn.2015.09.005
- 16. Erol O and Yanik YT. Evaluation of self-efficacy levels of individuals with type 2 diabetes. J Anatol Nurs Health Sci. 2016; 19(3):45-9 https://doi.org/10.17049/ahsbd.22818
- 17. Takci MA, Yildirim G. The Effect of education given to patients with diabetes in line with health belief model on their health belief, perception of self-efficacy and decision-making level. Lokman Hekim J History Med Folk Med 2021; 11(1): 73-82. https://doi.org/10.31020/mutftd.752988
- 18. Gedik S and Kocoglu D. Self-efficacy level among patients with type 2 diabetes living in rural areas. Rural Remote Health 2018; 18(1): 4262. https://doi.org/10.22605/RRH4262
- 19. Kilic M, Arslan S. Evaluation of health locus of control of individuals with type 2 diabetes. TJFMPC 2018; 12(2): 126-35. https://doi.org/10.21763/tjfmpc.432547
- 20. Arpaci Eren I. [The effect of diabetes school on perception of self-efficacy in people with diabetes] (In Turkish). 2018, Hasan Kalyoncu Univ. http://openaccess.hku.edu.tr/xmlui/handle/20.500.11782/1717 (Access date: June 21, 2020)
- 21. Ozdemir A, Kavak F, Gultekin A. Determining the self-efficacy perceived with social support in type ii diabetes patients. Turkiye Klinikleri J Nurs Sci 2019; 11(3):21-6. https://doi.org/10.5336/nurses.2019-64774
- 22. Beckerle CM. and Lavin MA. Association of self-efficacy and self-care with glycemic control in diabetes. Diabetes Spectrum, 2013; 26(3):172-78. https://doi.org/10.2337/diaspect.26.3.172
- 23. Cherrington A, Wallston KA and Rothman RL. Exploring the relationship between diabetes self-efficacy, depressive symptoms, and glycemic control among men and women with type 2 diabetes. J Behav Med 2010; 33(1): 81-9. https://doi.org/10.1007/s10865-009-9233-4
- 24. Erol O and Enc N. Hypoglycemia fear and self-efficacy of Turkish patients receiving insulin therapy. Asian Nurs Res 2011; 5(4): 222-8. https://doi.org/10.1016/j.anr.2011.12.001
- 25. Aminde LN, Tindong M, Ngwasiri CA, Aminde JA, Njim T, Fondong AA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endoc Dis 2019; 19(1): 35. https://doi.org/10.1186/s12902-019-0360-9
- 26. Krueger KL, Botermann SG, Schorr N, Griese-Mammen U. Laufs and Schulz M. Age-related medication adherence in patients with chronic heart failure: a systematic literature review. Int J Cardiology 2015; 184: 728-35. https://doi.org/10.1016/j.ijcard.2015.03.042
- 27. Van Der Wal MH, Jaarsma T, Moser DK, Veeger NJ, Van Gilst VH and Van Veldhuisen DJ. Compliance in heart failure patients: the importance of knowledge and beliefs. Eu Heart J 2006; 27(4): 434-40. https://doi.org/10.1093/eurheartj/ehi603
- 28. Abebaw MA, Messele M, Hailu M and Zewdu F. Adherence and associated factors towards antidiabetic medication among type II diabetic patients on follow-up at University of Gondar Hospital, Northwest Ethiopia. Advanc Nurs 2016. https://doi.org/10.1155/2016/8579157
| APA | ŞAHİN H, Ersoy S, PALA E (2021). Self-efficacy, medical adherence and related factors in patients with diabetes. , 13 - 21. 10.22391/fppc.809768 |
| Chicago | ŞAHİN Hacı Öztürk,Ersoy Süleyman,PALA Emin Self-efficacy, medical adherence and related factors in patients with diabetes. (2021): 13 - 21. 10.22391/fppc.809768 |
| MLA | ŞAHİN Hacı Öztürk,Ersoy Süleyman,PALA Emin Self-efficacy, medical adherence and related factors in patients with diabetes. , 2021, ss.13 - 21. 10.22391/fppc.809768 |
| AMA | ŞAHİN H,Ersoy S,PALA E Self-efficacy, medical adherence and related factors in patients with diabetes. . 2021; 13 - 21. 10.22391/fppc.809768 |
| Vancouver | ŞAHİN H,Ersoy S,PALA E Self-efficacy, medical adherence and related factors in patients with diabetes. . 2021; 13 - 21. 10.22391/fppc.809768 |
| IEEE | ŞAHİN H,Ersoy S,PALA E "Self-efficacy, medical adherence and related factors in patients with diabetes." , ss.13 - 21, 2021. 10.22391/fppc.809768 |
| ISNAD | ŞAHİN, Hacı Öztürk vd. "Self-efficacy, medical adherence and related factors in patients with diabetes". (2021), 13-21. https://doi.org/10.22391/fppc.809768 |
| APA | ŞAHİN H, Ersoy S, PALA E (2021). Self-efficacy, medical adherence and related factors in patients with diabetes. Aile Hekimliği ve Palyatif Bakım, 6(1), 13 - 21. 10.22391/fppc.809768 |
| Chicago | ŞAHİN Hacı Öztürk,Ersoy Süleyman,PALA Emin Self-efficacy, medical adherence and related factors in patients with diabetes. Aile Hekimliği ve Palyatif Bakım 6, no.1 (2021): 13 - 21. 10.22391/fppc.809768 |
| MLA | ŞAHİN Hacı Öztürk,Ersoy Süleyman,PALA Emin Self-efficacy, medical adherence and related factors in patients with diabetes. Aile Hekimliği ve Palyatif Bakım, vol.6, no.1, 2021, ss.13 - 21. 10.22391/fppc.809768 |
| AMA | ŞAHİN H,Ersoy S,PALA E Self-efficacy, medical adherence and related factors in patients with diabetes. Aile Hekimliği ve Palyatif Bakım. 2021; 6(1): 13 - 21. 10.22391/fppc.809768 |
| Vancouver | ŞAHİN H,Ersoy S,PALA E Self-efficacy, medical adherence and related factors in patients with diabetes. Aile Hekimliği ve Palyatif Bakım. 2021; 6(1): 13 - 21. 10.22391/fppc.809768 |
| IEEE | ŞAHİN H,Ersoy S,PALA E "Self-efficacy, medical adherence and related factors in patients with diabetes." Aile Hekimliği ve Palyatif Bakım, 6, ss.13 - 21, 2021. 10.22391/fppc.809768 |
| ISNAD | ŞAHİN, Hacı Öztürk vd. "Self-efficacy, medical adherence and related factors in patients with diabetes". Aile Hekimliği ve Palyatif Bakım 6/1 (2021), 13-21. https://doi.org/10.22391/fppc.809768 |
